Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
N/A
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 598 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
LB Pharmaceuticals Inc Common Stock
Market Cap
$975.87M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$982.12M
Operating Margin
-130.20%
TTM Avg
-311.82%
3Y Avg
-583.08%
5Y Avg
-487.88%
Market Cap
$987.11M
Operating Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$987.45M
Operating Margin
-1149.52%
TTM Avg
-2324.93%
3Y Avg
-1162.47%
5Y Avg
-1162.47%
Market Cap
$1.00B
Operating Margin
-1576.67%
TTM Avg
-1255.13%
3Y Avg
-1048.04%
5Y Avg
-849.59%
Market Cap
$1.01B
Operating Margin
4.18%
TTM Avg
2.97%
3Y Avg
7.13%
5Y Avg
8.72%
Market Cap
$1.01B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-59.79%
Market Cap
$1.01B
Operating Margin
-377.11%
TTM Avg
-200.94%
3Y Avg
-143.24%
5Y Avg
-174.04%
Market Cap
$1.02B
Operating Margin
1.38%
TTM Avg
4.21%
3Y Avg
3.61%
5Y Avg
3.61%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LB Pharmaceuticals Inc Common Stock (LBRX) | $975.87M | 0.00% | 0.00% | N/A | N/A |
| MeiraGTx Holdings plc (MGTX)vs › | $982.12M | -130.20% | -311.82% | -583.08% | -487.88% |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $987.11M | N/A | N/A | N/A | N/A |
| Aktis Oncology, Inc. (AKTS)vs › | $987.45M | -1149.52% | -2324.93% | -1162.47% | -1162.47% |
| Janux Therapeutics, Inc. (JANX)vs › | $1.00B | -1576.67% | -1255.13% | -1048.04% | -849.59% |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.01B | 4.18% | 2.97% | 7.13% | 8.72% |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $1.01B | 0.00% | 0.00% | 0.00% | -59.79% |
| Immatics N.V. (IMTX)vs › | $1.01B | -377.11% | -200.94% | -143.24% | -174.04% |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.02B | 1.38% | 4.21% | 3.61% | 3.61% |
| CeriBell, Inc. (CBLL)vs › | $931.87M | -68.62% | -63.13% | -82.91% | -82.91% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
